Latest Stories

Menarini brings Nobel Prize-winning scientist to Manila

Nobel prize-winning scientist recently shared his expertise with local cardiologists.

Prof. Louis J. Ignarro spoke during the 44th annual convention of the Philippine Heart Association (PHA), which was held at the Edsa Shangri-La Hotel in Mandaluyong City. His talk was viewed simultaneously via live streaming by PHA members in Baguio, Pampanga, Batangas and Davao.

This is in line with A. Menarini Philippines’ commitment to enhance the quality of cardiovascular disease management in the country.

A distinguished professor of Pharmacology at the UCLA School of Medicine in California, Ignarro received the Nobel Prize in Medicine in 1998 for his discovery that nitric oxide is produced in the blood vessels and controls the flow of blood by signaling the vessels to expand and contract.

“By causing blood vessels to widen, nitric oxide improves blood flow and lowers blood pressure,” Ignarro said.

With the theme “PHA@60: Strategies, Realities and Networks,” this year’s annual convention coincided with PHA’s 60th anniversary and was aimed at equipping Filipino cardiologists and physicians with the latest updates and innovations in cardiovascular medicine.

PHA president Dr. Saturnino Javier said: “We are honored to have Prof. Ignarro as a speaker in our annual convention. His extensive research on cardiovascular health and discovery of the role of nitric oxide have contributed significantly to the effective treatment of cardiovascular diseases.”

“Prof. Ignarro’s groundbreaking discovery of nitric oxide’s role in cardiovascular health paved the way for the development of effective treatments against hypertension,” said Dr. Dante Morales, Manila Doctors Hospital senior vice president for medical affairs. “Hypertension is a major risk factor for cardiovascular disease, the leading cause of death in the country.”

Congratulating the PHA on its 60th anniversary, A. Menarini Philippines general manager Ninia Torres said, “We fully support the association’s noble mission to ensure accessible, affordable and quality cardiovascular care for every Filipino.” A. Menarini Philippines is the local affiliate of Italy’s leading research-based pharmaceutical  company, the Menarini Group.

“Menarini is committed to working with Filipino physicians in reducing the burden of hypertension in the Philippines,” said John Graham,  A. Menarini Asia Pacific Pte. Ltd. chief executive officer.

Menarini recently introduced nebivolol in the Philippines. Nebivolol is the only beta blocker known to induce vascular production of nitric oxide. Available in Europe since 1999, nebivolol is indicated for the treatment of essential hypertension, and mild and moderate chronic heart failure in addition to standard therapies in elderly patients.

Follow Us

Follow us on Facebook Follow on Twitter Follow on Twitter

Recent Stories:

Complete stories on our Digital Edition newsstand for tablets, netbooks and mobile phones; 14-issue free trial. About to step out? Get breaking alerts on your mobile.phone. Text ON INQ BREAKING to 4467, for Globe, Smart and Sun subscribers in the Philippines.

Tags: cardiology , Health , nobel prize winner , Philippine heart association

Copyright © 2014, .
To subscribe to the Philippine Daily Inquirer newspaper in the Philippines, call +63 2 896-6000 for Metro Manila and Metro Cebu or email your subscription request here.
Factual errors? Contact the Philippine Daily Inquirer's day desk. Believe this article violates journalistic ethics? Contact the Inquirer's Reader's Advocate. Or write The Readers' Advocate:
c/o Philippine Daily Inquirer Chino Roces Avenue corner Yague and Mascardo Streets, Makati City, Metro Manila, Philippines Or fax nos. +63 2 8974793 to 94


  • Camilla’s brother dies of NYC head injury
  • Nepal officials go to Everest to try to end crisis
  • Escudero ready to defend self should name appear in Napoles’ list
  • Obama calls for peaceful end to island dispute
  • Russia not abiding by agreement on Ukraine—Obama
  • Sports

  • Promoters Dela Hoya, Arum in talks for Pacquiao-Alvarez—report
  • Benzema guides Madrid to 1-0 win over Bayern
  • Suns’ Goran Dragic win NBA’s Most Improved Player award
  • Heat go up 2-0, hold off Bobcats 101-97
  • Ronaldo shakes off injury fears to play Bayern
  • Lifestyle

  • Photos explore dynamics of youths’ sexual identity
  • 12th Philippine Food Expo set at the World Trade Center
  • No tourist draw, Malang the croc will remain wild
  • The best flavors of summer in one bite, and more
  • Homemade yogurt, bread blended with pizza, even ramen
  • Entertainment

  • Has Ai Ai fallen deeply with ‘sireno?’
  • Sony developing live-action Barbie comedy
  • California court won’t review Jackson doctor case
  • Return of ‘Ibong Adarna’
  • Practical Phytos plans his future
  • Business

  • Facebook profits triple as mobile soars
  • Insular Honors Sales Performers at Testimonial Rites
  • Apple increases stock buyback, will split stock
  • Cost-recovery provisions for affected gencos urged
  • This time, BIR goes after florists
  • Technology

  • Enrile in Masters of the Universe, Lord of the Rings?
  • Top Traits of Digital Marketers
  • No truth to viral no-visa ‘chronicles’
  • ‘Unlimited’ Internet promos not really limitless; lawmakers call for probe
  • Viber releases new design for iPhone, comes to Blackberry 10 for the first time
  • Opinion

  • Editorial cartoon, April 24, 2014
  • Talking to Janet
  • Respite
  • Bucket list
  • JPII in 1981: walking a tightrope
  • Global Nation

  • PH-HK relations repaired, but families of victims still being courted
  • Filipinos in Middle East urged to get clearance before returning
  • PH seeks ‘clearer assurance’ from US
  • China and rivals sign naval pact to ease maritime tensions
  • What Went Before: Manila bus hostage crisis
  • Marketplace